Open access
Jul 2026
Computational drug repurposing identifies flavoxate as a novel NLRP3 inflammasome inhibitor for Alzheimer’s disease therapy
Gajendra Choudhary, Harshita Rajput, Rutweek Kulkarni et al.
· In Silico Pharmacology · 0 citations